7071 — Amvis Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual income statement for Amvis Holdings, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2019 September 30th	R2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,370	9,174	15,334	23,072	31,985
Cost of Revenue
Gross Profit	2,148	3,750	6,305	9,687	13,271
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,466	7,299	11,550	16,940	22,955
Operating Profit	903	1,875	3,784	6,132	9,030
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	858	1,777	3,779	6,060	8,942
Provision for Income Taxes
Net Income After Taxes	603	1,239	2,628	4,280	6,311
Net Income Before Extraordinary Items
Net Income	603	1,239	2,628	4,280	6,311
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	603	1,239	2,627	4,279	6,310
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.8	13.6	27.7	43.7	61.2
Dividends per Share